Singapore markets open in 3 minutes

Rhythm Pharmaceuticals, Inc. (RYTM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
39.71-0.29 (-0.73%)
At close: 04:00PM EDT
39.01 -0.70 (-1.76%)
After hours: 04:06PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.41B
Enterprise value 2.13B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)29.79
Price/book (mrq)14.17
Enterprise value/revenue 27.52
Enterprise value/EBITDA -12.65

Trading information

Stock price history

Beta (5Y monthly) 1.93
52-week change 390.02%
S&P500 52-week change 325.01%
52-week high 352.57
52-week low 315.50
50-day moving average 342.45
200-day moving average 333.45

Share statistics

Avg vol (3-month) 3585.78k
Avg vol (10-day) 3531.61k
Shares outstanding 560.14M
Implied shares outstanding 660.58M
Float 844.98M
% held by insiders 10.54%
% held by institutions 1112.28%
Shares short (28 Mar 2024) 49.74M
Short ratio (28 Mar 2024) 416.42
Short % of float (28 Mar 2024) 425.99%
Short % of shares outstanding (28 Mar 2024) 416.19%
Shares short (prior month 29 Feb 2024) 49M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -238.52%
Operating margin (ttm)-170.28%

Management effectiveness

Return on assets (ttm)-32.22%
Return on equity (ttm)-85.10%

Income statement

Revenue (ttm)77.43M
Revenue per share (ttm)1.34
Quarterly revenue growth (yoy)175.70%
Gross profit (ttm)N/A
EBITDA -182.6M
Net income avi to common (ttm)-184.68M
Diluted EPS (ttm)-3.20
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)275.85M
Total cash per share (mrq)4.59
Total debt (mrq)107.4M
Total debt/equity (mrq)63.27%
Current ratio (mrq)5.58
Book value per share (mrq)2.86

Cash flow statement

Operating cash flow (ttm)-136.16M
Levered free cash flow (ttm)-91.47M